Assessment of platelet respiration as emerging biomarker of disease
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
30904011
DOI
10.33549/physiolres.934032
PII: 934032
Knihovny.cz E-zdroje
- MeSH
- biologické markery metabolismus MeSH
- buněčné dýchání fyziologie MeSH
- energetický metabolismus fyziologie MeSH
- lidé MeSH
- mitochondrie metabolismus MeSH
- nemoci srdce diagnóza metabolismus MeSH
- neurodegenerativní nemoci diagnóza metabolismus MeSH
- spotřeba kyslíku fyziologie MeSH
- trombocyty metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- biologické markery MeSH
Mitochondrial dysfunction is currently acknowledged as a central pathomechanism of most common diseases of the 21(st) century. Recently, the assessment of the bioenergetic profile of human peripheral blood cells has emerged as a novel research field with potential applications in the development of disease biomarkers. In particular, platelets have been successfully used for the ex vivo analysis of mitochondrial respiratory function in several acute and chronic pathologies. An increasing number of studies support the idea that evaluation of the bioenergetic function in circulating platelets may represent the peripheral signature of mitochondrial dysfunction in metabolically active tissues (brain, heart, liver, skeletal muscle). Accordingly, impairment of mitochondrial respiration in peripheral platelets might have potential clinical applicability as a diagnostic and prognostic tool as well as a biomarker in treatment monitoring. The aim of this minireview is to summarize current information in the field of platelet mitochondrial dysfunction in both acute and chronic diseases.
Citace poskytuje Crossref.org
Impact of aging on mitochondrial respiration in various organs
Mitochondrial respiration of human platelets in young adult and advanced age - Seahorse or O2k?